AIC
SPRB

AWM Investment Company’s Spruce Biosciences SPRB Stock Holding History

AWM Investment Company’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,667
Closed -$157K – 113
2024
Q1 		$157K Buy
+2,667
New +$678K 0.02% 113
2021
Q1 		– Sell
-533
Closed -$972K – 118
2020
Q4 		$972K Buy
+533
New +$884K 0.12% 91

Other funds holding SPRB

RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

AWM Investment Company's SPRB Position: Q2 2024 in Review

AWM Investment Company sold out of Spruce Biosciences (SPRB) in Q2 2024, closing a stake of 2,667 shares — an estimated $157K sold.

AWM Investment Company first reported a position in SPRB in Q4 2020 and held it in 2 quarters. The position peaked at $972K in Q4 2020. 37 funds tracked by Wall St. Rank hold SPRB as of Q2 2024.

  • AWM Investment Company reported no remaining Spruce Biosciences position as of Q2 2024 after selling out during the quarter.
  • AWM Investment Company sold 2,667 Spruce Biosciences shares in Q2 2024, an estimated $157K.
  • AWM Investment Company first reported a position in Spruce Biosciences in Q4 2020 and held it in 2 quarters.
  • AWM Investment Company's Spruce Biosciences position peaked at $972K in Q4 2020.
  • 37 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2024.

Based on AWM Investment Company's 13F filing for Q2 2024, filed 14 Aug 2024.